Publications

1. Banks SA, Abeykoon JP, Rech K, Morris P, Tan QKG, Veres LN, Schoonover KL, Aksamit AJ, Keating GF, Kissoon N, Sominidi Damodaran S, Maredia HS, Davidge-Pitts CJ, Villasboas JC, Go R, Tobin WO, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. SLC29A3 Pathogenic Variants Resulting in Dural Based Fibroinflammatory Mass Lesions and H Syndrome Treated With Cobimetinib: A Case Report. Neurol Genet. 2024 Dec; 10 (6):e200197 Epub 2024 Oct 14
   View PubMed
2. Nathoo N, Larson DP, Guo Y, Giannini C, Lucchinetti CF, Micallef IN, Rech KL, Jevremovic D, Lachance DH, Abeykoon JP, Go RS, Tobin WO. Central nervous system crystal-storing histiocytosis: A case report and literature review. Eur J Neurol. 2024 Oct 25; e16528 [Epub ahead of print]
   View PubMed
3. Mangioris G, Pittock SJ, Yang B, Fryer JP, Harmsen WS, Dubey D, Flanagan EP, Lopez-Chiriboga SA, McKeon A, Mills JR, Vodopivec I, Tobin WO, Toledano M, Aksamit AJ, Zekeridou A. Cerebrospinal Fluid Cytokine and Chemokine Profiles in Central Nervous System Sarcoidosis: Diagnostic and Immunopathologic Insights. Ann Neurol. 2024 Oct; 96 (4):704-714 Epub 2024 July 19
   View PubMed
4. Nathoo N, Uhm JH, Porter AB, Hammack J, Jaeckle KA, Mrugala MM, Crum BA, Flanagan EP, Pittock SJ, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Bach C, Ravindran A, Sartori Valinotti JC, Bennani NN, Abeykoon JP, Shah MV, Hook CC, Rech KL, Go RS, Tobin WO, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Clinical features and outcomes in primary nervous system histiocytic neoplasms. Blood Cancer J 2024 Jun 20; 14 (1):101 Epub 2024 June 20
   View PubMed
5. Moheb N, Tobin WO, Olsen TW, Chen JJ. Teaching NeuroImage: Fundoscopic and Optical Coherence Tomography Changes in Primary CNS Lymphoma. Neurology. 2024 Jun; 102 (11):e209512 Epub 2024 May 09
   View PubMed
6. Dominguez L, McKeon A, Tobin WO, Lopez-Chiriboga S. Long term outcomes in patients with anti-DPPX autoimmunity. J Neuroimmunol. 2023 Nov 15; 384:578214. Epub 2023 Sep 30.
   View PubMed
7. Goyal G, Acosta-Medina AA, Abeykoon JP, Dai C, Ravindran A, Vassallo R, Ryu JH, Shah MV, Bennani NN, Young JR, Bach CR, Ruan GJ, Zanwar S, Tobin WO, Koster MJ, Davidge-Pitts CJ, Gruber LM, Dasari S, Rech KL, Go RS. Long-term outcomes among adults with Langerhans cell histiocytosis. Blood Adv. 2023 Nov 14; 7 (21):6568-6578
   View PubMed
8. Acosta-Medina AA, Kemps PG, Zondag TCE, Abeykoon JP, Forma-Borst J, Steenwijk EC, Feijen EAM, Teepen JC, Bennani NN, Schram SM, Shah MV, Davidge-Pitts C, Koster MJ, Ryu JH, Vassallo R, Tobin WO, Young JR, Dasari S, Rech K, Ravindran A, Cleven AHG, Verdijk RM, van Noesel CJM, Balgobind BV, Bouma GJ, Saeed P, Bramer JAM, de Groen RAL, Vermaat JSP, van de Sande MAJ, Smit EF, Langerak AW, van Wezel T, Tonino SH, van den Bos C, van Laar JAM, Go RS, Goyal G, van Halteren AGS. BRAF V600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis. Blood. 2023 Nov 2; 142 (18):1570-1575
   View PubMed
9. Rotter J, Kumar R, Nesvick CL, Krauss WE, Giannini C, Tobin WO. Teaching NeuroImage: Olfactory Stem Cell Injection Inducing Actively Secreting Respiratory Epithelium in a Cervical Syrinx. Neurology. 2023 Sep 12; 101 (11):497-498 Epub 2023 July 03
   View PubMed
10. Banks SA, Bhatti MT, Go RS, Abeykoon JP, Acosta-Medina AA, Hazim AZ, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Garrity JA, Tobin WO. Reply. Ophthalmology 2023 Sep; 130 (9):e33-e34 Epub 2023 June 10
    View PubMed
11. Fereidan-Esfahani M, Decker PA, Weigand SD, Lopez Chiriboga AS, Flanagan EP, Tillema JM, Lucchinetti CF, Eckel-Passow JE, Tobin WO. Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients. Ann Clin Transl Neurol. 2023 Sep; 10 (9):1544-1555 Epub 2023 July 13
    View PubMed
12. Nathoo N, Gavrilova RH, Trejo-Lopez JA, McGarrah PW, Go RS, Alqallaf A, Tobin WO. Recurrent Tumefactive Central Nervous System Lesions Due to BRIP1 -Related Fanconi Anemia. Neurologist. 2023 Sep 1; 28 (5):332-334 Epub 2023 Sept 01
    View PubMed
13. Gadoth A, Devine MF, Pittock SJ, McKeon A, Tobin WO, Gossard TR, Cattaneo EFD, McCarter SJ, St Louis EK. Sleep disturbances associated with DPPX autoantibodies: a case series. J Neurol. 2023 Jul; 270 (7):3543-3552 Epub 2023 Apr 07
    View PubMed
14. Muhammad S, McPhail ED, Tobin WO, Dasari S, Theis J, Vrana JA, Naddaf E. A second case of liraglutide-type localised amyloidosis. Amyloid. 2023 Jun; 30 (2):244-245 Epub 2022 Dec 08
    View PubMed
15. Chohan KL, Abeykoon JP, Young JR, Tobin WO, Koster MJ, Shah MV, Ryu JH, Vassallo R, Rech KL, Ravindran A, Goyal G, Go RS, Bennani NN. Sirolimus as frontline therapy for PTEN-mutated histiocytic sarcoma. Haematologica. 2023 Jun 1; 108 (6):1702-1706 Epub 2023 June 01
    View PubMed
16. Banks SA, Sartori Valinotti JC, Go RS, Abeykoon JP, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Ravindran A, Bennani NN, Shah MV, Rech KL, Tobin WO, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group and Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology. Neurological Manifestations of Histiocytic Disorders. Curr Neurol Neurosci Rep. 2023 Jun; 23 (6):277-286 Epub 2023 May 20
    View PubMed
17. Jackson-Tarlton C, Londono D, Lucchinetti CF, Duffy DJ, Weigand SD, Tillema JM, Kalinowska-Lyszczarz A, Tobin WO. ADC restriction is not associated with clinical response to plasma exchange following a cerebral attack of multiple sclerosis. Mult Scler Relat Disord. 2023 May; 73:104676 Epub 2023 Mar 30
    View PubMed
18. Jackson-Tarlton CS, Keegan BM, Fereidan-Esfahani M, Barakat BO, Decker PA, Lucchinetti CF, Eckel-Passow J, Tobin WO. Spinal cord and brain corticospinal tract lesions are associated with motor progression in tumefactive multiple sclerosis. Mult Scler Relat Disord. 2023 May; 73:104614 Epub 2023 Mar 12
    View PubMed
19. Benson JC, Vaubel R, Ebne BA, Mark IT, Peris Celda M, Hook CC, Tobin WO, Giannini C. Erdheim-Chester Disease. AJNR Am J Neuroradiol. 2023 May; 44 (5):505-510 Epub 2023 Mar 30
    View PubMed
20. Cacciaguerra L, Morris P, Tobin WO, Chen JJ, Banks SA, Elsbernd P, Redenbaugh V, Tillema JM, Montini F, Sechi E, Lopez-Chiriboga AS, Zalewski N, Guo Y, Rocca MA, Filippi M, Pittock SJ, Lucchinetti CF, Flanagan EP. Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder. Neurology. 2023 Mar 28; 100 (13):e1418-e1432 Epub 2023 Jan 23
    View PubMed
21. Kalinowska-Lyszczarz A, Tillema JM, Tobin WO, Guo Y, Weigand SD, Metz I, Bruck W, Lassmann H, Giraldo-Chica M, Port JD, Lucchinetti CF. Long-term clinical, imaging and cognitive outcomes association with MS immunopathology. Ann Clin Transl Neurol. 2023 Mar; 10 (3):339-352 Epub 2023 Feb 09
    View PubMed
22. Banks SA, Bhatti MT, Go RS, Abeykoon JP, Acosta-Medina AA, Hazim AZ, Goyal G, Young JR, Koster MJ, Vassallo R, Ryu JH, Davidge-Pitts CJ, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Garrity JA, Tobin WO, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Ophthalmologic Involvement in Adults with Histiocytic Disorders: Clinical Presentation and Treatment Outcomes. Ophthalmology. 2023 Jan; 130 (1):77-86 Epub 2022 Aug 03
    View PubMed
23. Abeykoon JP, Rech KL, Young JR, Ravindran A, Ruan GJ, Dasari S, Morlote DM, King RL, Rummage C, Zanwar S, Acosta-Medina AM, Tobin WO, Shah MV, Bennani NN, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Witzig TE, Goyal G, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Outcomes After Treatment With Cobimetinib in Patients With Rosai-Dorfman Disease Based on KRAS and MEK Alteration Status. JAMA Oncol. 2022 Dec 1; 8 (12):1816-1820
    View PubMed
24. Hazim AZ, Acosta-Medina AA, Young JR, Ruan GJ, Abeykoon JP, Ravindran A, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Bennani NN, Rech KL, Shah MV, Witzig TE, Goyal G, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Classical and non-classical phenotypes of Erdheim-Chester disease: Correlating clinical, radiographic and genotypic findings. Br J Haematol 2022 Nov; 199 (3):454-457 Epub 2022 Aug 26
    View PubMed
25. Hardy TA, Guo Y, Flanagan EP, Lucchinetti CF, Tobin WO. The clinical spectrum of haemorrhagic CNS inflammatory demyelinating lesions. Mult Scler. 2022 Oct; 28 (11):1710-1718 Epub 2022 May 17
    View PubMed
26. Eckel-Passow JE, Lachance DH, Decker PA, Kollmeyer TM, Kosel ML, Drucker KL, Slager S, Wrensch M, Tobin WO, Jenkins RB. Inherited genetics of adult diffuse glioma and polygenic risk scores-a review. Neurooncol Pract. 2022 Aug; 9 (4):259-270 Epub 2022 Mar 12
    View PubMed
27. Hu M, Goyal G, Abeykoon JP, Acosta-Medina AA, Ruan GJ, Young JR, Ravindran A, Bennani NN, Shah MV, Vassallo R, Ryu JH, Davidge-Pitts CJ, Koster MJ, Tobin WO, Sartori-Valinotti JC, Rech KL, Go RS. Clinical features and outcomes of non-pulmonary unifocal adult Langerhans cell histiocytosis. Blood Cancer J 2022 Jun 3; 12 (6):89 Epub 2022 June 03
    View PubMed
28. Gupta R, Day CN, Tobin WO, Crowson CS. Understanding the effect of categorization of a continuous predictor with application to neuro-oncology. Neurooncol Pract. 2022 Apr; 9 (2):87-90 Epub 2021 Aug 04
    View PubMed
29. Goyal G, Young JR, Abeykoon JP, Shah MV, Bennani NN, Sartori-Valinotti JC, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Davidge-Pitts CJ, Ravindran A, Rech KL, Go RS. Impact of a Multidisciplinary Tumor Board on the Care of Patients with Histiocytic Disorders: The Histiocytosis Working Group experience. Oncologist. 2022 Mar 4; 27 (2):144-148
    View PubMed
30. Abeykoon JP, Lasho TL, Dasari S, Rech KL, Ranatunga WK, Manske MK, Tischer A, Ravindran A, Young JR, Tobin WO, Flanagan EP, Nowakowski KE, Ruan GJ, Shah MV, Bennani NN, Vassallo R, Ryu JH, Koster MJ, Davidge-Pitts CJ, Patnaik MM, Wu X, Witzig TE, Goyal G, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Sustained, complete response to pexidartinib in a patient with CSF1R-mutated Erdheim-Chester disease. Am J Hematol. 2022 Mar 1; 97 (3):293-302 Epub 2022 Jan 03
    View PubMed
31. Fereidan-Esfahani M, Decker PA, Eckel Passow JE, Lucchinetti CF, Flanagan EP, Tobin WO. Population-based incidence and clinico-radiological characteristics of tumefactive demyelination in Olmsted County, Minnesota, United States. Eur J Neurol. 2022 Mar; 29 (3):782-789 Epub 2021 Dec 09
    View PubMed
32. Kalinowska-Lyszczarz A, Tillema JM, Tobin WO, Guo Y, Fitz-Gibbon PD, Weigand SD, Giraldo-Chica M, Port JD, Lucchinetti CF. Long-term clinical, MRI, and cognitive follow-up in a large cohort of pathologically confirmed, predominantly tumefactive multiple sclerosis. Mult Scler. 2022 Mar; 28 (3):441-452 Epub 2021 July 02
    View PubMed
33. Lim ST, Tobin WO, Murphy S, Kinsella JA, Smith DR, Lim SY, Murphy SM, Coughlan T, Collins DR, O'Neill D, Egan B, Tierney S, McCabe D. Profile of reticulated platelets in the early, subacute and late phases after transient ischemic attack or ischemic stroke. Platelets. 2022 Jan 2; 33 (1):89-97 Epub 2020 Dec 21
    View PubMed
34. Hazim AZ, Ruan GJ, Hu M, Ravindran A, Rech KL, Young JR, Cox CW, Abeykoon JP, Scheckel C, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Bennani NN, Shah MV, Goyal G, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival. Am J Hematol. 2021 Dec 01; 96(12):1604-1610. Epub 2021 Oct 08.
    View PubMed
35. Tobin WO, Kalinowska-Lyszczarz A, Weigand SD, Guo Y, Tosakulwong N, Parisi JE, Metz I, Frischer JM, Lassmann H, Bruck W, Linbo L, Lucchinetti CF. Clinical Correlation of Multiple Sclerosis Immunopathologic Subtypes. Neurology. 2021 Nov 9; 97 (19):e1906-e1913 Epub 2021 Sept 09
    View PubMed
36. Metz I, Gavrilova RH, Weigand SD, Frischer JM, Popescu BF, Guo Y, Gloth M, Tobin WO, Zalewski NL, Lassmann H, Tillema JM, Erickson BJ, Parisi JE, Becker S, Konig FB, Bruck W, Lucchinetti CF. Magnetic Resonance Imaging Correlates of Multiple Sclerosis Immunopathological Patterns. Ann Neurol. 2021 Sep; 90 (3):440-454 Epub 2021 July 19
    View PubMed
37. Boes CJ, Klaas JP, Tobin WO, Flanagan EP, McKeon A, Braksick SA, Burkholder DB, Stitt DW, Cutsforth-Gregory JK. Harry Lee Parker: Games Lost and Won on the Playing Fields of Neurology. Mayo Clin Proc Innov Qual Outcomes. 2021 Aug; 5 (4):701-719 Epub 2021 July 15
    View PubMed
38. Jolliffe EA, Guo Y, Hardy TA, Morris PP, Flanagan EP, Lucchinetti CF, Tobin WO. Clinical and Radiologic Features, Pathology, and Treatment of Balo Concentric Sclerosis. Neurology. 2021 Jul 27; 97 (4):e414-e422 Epub 2021 May 19
    View PubMed
39. Sechi E, Buciuc M, Pittock SJ, Chen JJ, Fryer JP, Jenkins SM, Budhram A, Weinshenker BG, Lopez-Chiriboga AS, Tillema JM, McKeon A, Mills JR, Tobin WO, Flanagan EP. Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing. JAMA Neurol. 2021 Jun 1; 78 (6):741-746
    View PubMed
40. Goyal G, Abeykoon JP, Hu M, Young JR, Shah MV, Bennani NN, Call TG, Hook CC, Pardanani A, Inwards DJ, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Davidge-Pitts CJ, Ravindran A, Rech KL, Go RS, Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Single-agent cladribine as an effective front-line therapy for adults with Langerhans cell histiocytosis. Am J Hematol 2021 May 1; 96 (5):E146-E150 Epub 2021 Feb 19
    View PubMed
41. Conte GM, Weston AD, Vogelsang DC, Philbrick KA, Cai JC, Barbera M, Sanvito F, Lachance DH, Jenkins RB, Tobin WO, Eckel-Passow JE, Erickson BJ. Generative Adversarial Networks to Synthesize Missing T1 and FLAIR MRI Sequences for Use in a Multisequence Brain Tumor Segmentation Model. Radiology. 2021 May; 299 (2):313-323 Epub 2021 Mar 09
    View PubMed
42. Joseph B, Nandakumar AL, Ahmed AT, Gopal N, Murad MH, Frye MA, Tobin WO, Singh B. Prevalence of bipolar disorder in multiple sclerosis: a systematic review and meta-analysis. Evid Based Ment Health. 2021 May; 24 (2):88-94 Epub 2020 Dec 16
    View PubMed
43. Budhram A, Rech KL, Peikert JM, Okuno SH, Go RS, Dubey D, Tobin WO. Teaching NeuroImages: Brain and Skin Involvement in Erdheim-Chester Disease. Neurology. 2021 Mar 16; 96 (11):e1590-e1592 Epub 2020 Nov 09
    View PubMed
44. Wilkins JM, Gakh O, Kabiraj P, McCarthy CB, Tobin WO, Howe CL, Lucchinetti CF. Correction for: Signatures of cell stress and altered bioenergetics in skin fibroblasts from patients with multiple sclerosis. Aging (Albany NY). 2021 Mar 3; 13 (5):7707 Epub 2021 Mar 03
    View PubMed
45. Fereidan-Esfahani M, Tobin WO. Cyclophosphamide in treatment of tumefactive multiple sclerosis. Mult Scler Relat Disord. 2021 Jan; 47:102627 Epub 2020 Nov 11
    View PubMed
46. Hazim AZ, Ruan GJ, Ravindran A, Abeykoon JP, Scheckel C, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Bennani NN, Rech KL, Young JR, Shah MV, Goyal G, Go RS. Efficacy of BRAF-Inhibitor Therapy in BRAF(V600E) -Mutated Adult Langerhans Cell Histiocytosis. Oncologist. 2020 Dec; 25 (12):1001-1004 Epub 2020 Oct 12
    View PubMed
47. Fereidan-Esfahani M, Tobin WO. Hirayama Disease Presenting as 4-Limb Paresthesia. Neurologist. 2020 Nov; 25 (6):187-189
    View PubMed
48. Ruan GJ, Hazim A, Abeykoon JP, Scheckel C, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Bennani NN, Rech KL, Young JR, Shah MV, Goyal G, Go RS. Low-dose vemurafenib monotherapy in BRAF(V600E) -mutated Erdheim-Chester disease. Leuk Lymphoma 2020 Nov; 61 (11):2733-2737 Epub 2020 July 01
    View PubMed
49. Kalinowska-Lyszczarz A, Fereidan-Esfahani M, Guo Y, Lucchinetti CF, Tobin WO. Pathological findings in central nervous system demyelination associated with infliximab. Mult Scler. 2020 Aug; 26 (9):1124-1129 Epub 2019 Dec 17
    View PubMed
50. Wilkins JM, Gakh O, Kabiraj P, McCarthy CB, Tobin WO, Howe CL, Lucchinetti CF. Signatures of cell stress and altered bioenergetics in skin fibroblasts from patients with multiple sclerosis. Aging (Albany NY). 2020 Jul 8; 12 (14):15134-15156 Epub 2020 July 08
    View PubMed
51. Goyal G, Young JR, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Davidge-Pitts CJ, Hurtado MD, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Go RS, Mayo Clinic Histiocytosis Working Group. The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease. Mayo Clin Proc. 2019 Oct; 94 (10):2054-2071 Epub 2019 Aug 28
    View PubMed
52. Petzold A, Woodhall M, Khaleeli Z, Tobin WO, Pittock SJ, Weinshenker BG, Vincent A, Waters P, Plant GT. Aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies in immune-mediated optic neuritis at long-term follow-up. J Neurol Neurosurg Psychiatry. 2019 Sep; 90 (9):1021-1026 Epub 2019 May 22
    View PubMed
53. Tobin WO. Management of Multiple Sclerosis Symptoms and Comorbidities. Continuum (Minneap Minn). 2019 Jun; 25 (3):753-772
    View PubMed
54. Goyal G, Lau D, Nagle AM, Vassallo R, Rech KL, Ryu JH, Davidge-Pitts CJ, Tobin WO, Koster MJ, Bennani NN, Shah MV, Liu MC, Go RS, Mayo Clinic Histiocytosis Working Group. Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms. Blood 2019 Apr 4; 133 (14):1607-1610 Epub 2019 Jan 29
    View PubMed
55. Goyal G, Lau D, Nagle AM, Vassallo R, Rech KL, Ryu JH, Davidge-Pitts CJ, Tobin WO, Koster MJ, Bennani NN, Shah MV, Liu MC, Go RS, Mayo Clinic Histiocytosis Working Group. Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms. Blood. 2019 Apr 4; 133(14):1607-1610. Epub 2019 Jan 29.
    View PubMed
56. Tobin WO. Growing the phenotype of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) in children. Dev Med Child Neurol 2019 Apr; 61 (4):391-392 Epub 2018 Sept 23
    View PubMed
57. Tobin WO, Keegan BM. Reply to: "Crowell et al. Idiopathic Central Nervous System Inflammatory Disease in the Setting of HLA-B27 Uveitis". Ocul Immunol Inflamm 2019; 27 (6):918-919 Epub 2018 June 29
    View PubMed
58. Chen JJ, Flanagan EP, Jitprapaikulsan J, Lopez-Chiriboga AS, Fryer JP, Leavitt JA, Weinshenker BG, McKeon A, Tillema JM, Lennon VA, Tobin WO, Keegan BM, Lucchinetti CF, Kantarci OH, McClelland CM, Lee MS, Bennett JL, Pelak VS, Chen Y, VanStavern G, Adesina OO, Eggenberger ER, Acierno MD, Wingerchuk DM, Brazis PW, Sagen J, Pittock SJ. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome. Am J Ophthalmol. 2018 Nov; 195:8-15 Epub 2018 July 26
    View PubMed
59. Parks NE, Pittock SJ, Mandrekar J, Kantarci OH, Lucchinetti CF, Weinshenker BG, Keegan BM, Tobin WO, Tillema JM, Toledano M, Flanagan EP. Population-based study of "no evident disease activity" in MS. Neurol Neuroimmunol Neuroinflamm. 2018 Nov; 5 (6):e495 Epub 2018 Aug 16
    View PubMed
60. Tobin WO, Guo Y, Keegan BM. Reply: Two cases of CLIPPERS with increased number of perivascular CD20-positive B lymphocytes. Brain 2018 Oct 1; 141 (10):e76
    View PubMed
61. Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG, McKeon A, Lennon VA, Leavitt JA, Tillema JM, Lucchinetti C, Keegan BM, Kantarci O, Khanna C, Jenkins SM, Spears GM, Sagan J, Pittock SJ. Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis. Ophthalmology. 2018 Oct; 125 (10):1628-1637 Epub 2018 Apr 30
    View PubMed
62. Johnson SA, Chen JJ, Tobin WO. Teaching NeuroImages: Optic nerve sheath meningioma presenting as gaze-evoked amaurosis. Neurology. 2018 Jun 5; 90 (23):e2095-e2096
    View PubMed
63. Marin Collazo IV, Howe CL, Lucchinetti CF, Tobin WO. Neuromyelitis Optica and Herpes Simplex Virus 2: A Viral Trigger for Aquaporin-4 Autoimmunity? Neurologist. 2018 May; 23 (3):92-93
    View PubMed
64. English SW, Keegan BM, Flanagan EP, Tobin WO, Zalewski NL. Clinical Reasoning: A 30-year-old man with headache and sleep disturbance. Neurology. 2018 Apr 24; 90 (17):e1535-e1540
    View PubMed
65. Chen JJ, Tobin WO, Majed M, Jitprapaikulsan J, Fryer JP, Leavitt JA, Flanagan EP, McKeon A, Pittock SJ. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial. JAMA Ophthalmol. 2018 Apr 1; 136 (4):419-422
    View PubMed
66. Tobin WO, Guo Y, Krecke KN, Keegan BM. Reply: A case of CLIPPERS challenging the new diagnostic criteria. Brain 2018 Feb 1; 141 (2):e13
    View PubMed
67. Parks NE, Goyal G, Go RS, Mandrekar J, Tobin WO. Neuroradiologic manifestations of Erdheim-Chester disease. Neurol Clin Pract. 2018 Feb; 8 (1):15-20
    View PubMed
68. Delaney S, O'Connor G, Reardon W, Murphy SJX, Tierney S, Ryan BM, Delaney H, Doherty CP, Guiney M, Brennan P, Tobin WO, McCabe DJH. Extracranial and Intracranial Vasculopathy With "Moyamoya Phenomenon" in Association With Alagille Syndrome. Front Neurol. 2018; 9:1194 Epub 2019 Jan 29
    View PubMed
69. Marin Collazo IV, Tobin WO. Facial Myokymia and Hemifacial Spasm in Multiple Sclerosis: A Descriptive Study on Clinical Features and Treatment Outcomes. Neurologist. 2018 Jan; 23 (1):1-6
    View PubMed
70. Tobin WO, Guo Y, Keegan BM. Reply: CLIPPERS, a possible symptomatic lymphohistiocytic immune reaction. Brain 2018 Jan 1; 141 (1):e6
    View PubMed
71. Tobin WO, Pittock SJ. Erratum: Autoimmune neurology of the central nervous system CONTINUUM: Lifelong Learning in Neurology. 2017 Oct; 23 (5):1238
    
72. Tobin WO, Guo Y, Krecke KN, Parisi JE, Lucchinetti CF, Pittock SJ, Mandrekar J, Dubey D, Debruyne J, Keegan BM. Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2017 Sep 1; 140 (9):2415-2425
    View PubMed
73. Zalewski NL, Tobin WO. CLIPPERS. Curr Neurol Neurosci Rep. 2017 Sep; 17 (9):65
    View PubMed
74. Tobin WO, Costanzi C, Guo Y, Parisi JE, Weigand SD, Lucchinetti CF. Clinical-radiological-pathological spectrum of central nervous system-idiopathic inflammatory demyelinating disease in the elderly. Mult Scler. 2017 Aug; 23 (9):1204-1213 Epub 2016 Oct 19
    View PubMed
75. Tobin WO, Weinshenker BG. Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS - NO. Mult Scler. 2017 Aug; 23 (9):1190-1192 Epub 2017 July 04
    View PubMed
76. Tobin WO, Pittock SJ. Autoimmune neurology of the central nervous system CONTINUUM: Lifelong Learning in Neurology. 2017 Jun; 23: (3)627-53.
    
77. Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Egan B, Feeley TM, Coughlan T, Collins DR, O'Neill D, Murphy S, Lim SJ, Murphy RP, McCabe D. Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes. J Neurol Sci. 2017 Apr 15; 375:404-410.
    View PubMed
78. Solomon AJ, Bourdette DN, Cross AH, Applebee A, Skidd PM, Howard DB, Spain RI, Cameron MH, Kim E, Mass MK, Yadav V, Whitham RH, Longbrake EE, Naismith RT, Wu GF, Parks BJ, Wingerchuk DM, Rabin BL, Toledano M, Tobin WO, Kantarci OH, Carter JL, Keegan BM, Weinshenker BG. The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study. Neurology. 2016 Sep 27; 87 (13):1393-9 Epub 2016 Aug 31
    View PubMed
79. Hardy TA, Tobin WO, Lucchinetti CF. Exploring the overlap between multiple sclerosis, tumefactive demyelination and Balo's concentric sclerosis. Mult Scler. 2016 Jul; 22 (8):986-92 Epub 2016 Apr 01
    View PubMed
80. Tobin WO, Popescu BF, Lowe V, Pirko I, Parisi JE, Kantarci K, Fields JA, Bruns MB, Boeve BF, Lucchinetti CF. Multiple sclerosis masquerading as Alzheimer-type dementia: Clinical, radiological and pathological findings. Mult Scler. 2016 Apr; 22 (5):698-704 Epub 2015 Oct 07
    View PubMed
81. Tobin WO, Meyer FB, Keegan BM. Diagnostic Yield and Safety of Cerebellar and Brainstem Parenchymal Biopsy. World Neurosurg. 2015 Dec; 84: (6)1973-6.
    View PubMed
82. Tobin WO, Weinshenker BG. Stopping immunomodulatory medications in MS: Frequency, reasons and consequences. Mult Scler Relat Disord. 2015 Sep; 4 (5):437-443 Epub 2015 July 08
    View PubMed
83. Tobin WO, Pittock SJ, Weinshenker BG, Yan Z. Teaching NeuroImages: Primary Sjogren syndrome presenting as isolated lesion of medulla oblongata. Neurology. 2015 Jul 14; 85(2):204-5.
    View PubMed
84. Kinsella JA, Tobin WO, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Feeley TM, Egan B, O'Neill D, Collins DR, Coughlan T, Harbison JA, Doherty CP, Madhavan P, Moore DJ, O'Neill SM, Colgan MP, Saqqur M, Murphy RP, Moran N, Hamilton G, McCabe DJ. Increased thrombin generation potential in symptomatic versus asymptomatic moderate or severe carotid stenosis and relationship with cerebral microemboli. J Neurol Neurosurg Psychiatry. 2015 Apr; 86(4):460-7. Epub 2014 Jul 17.
    View PubMed
85. von Sarnowski B, Schminke U, Grittner U, Fazekas F, Tanislav C, Kaps M, Tatlisumak T, Putaala J, Haeusler KG, Silva ADBDE, Kinsella JA, McCabe DJH, Tobin WO, Huber R, Willeit J, Furtner M, Bodechtel U, Rolfs A, Kessler C, Hennerici MG. Cervical artery dissection in young adults in the stroke in young fabry patients (sifap1) study. Cerebrovasc Dis. 2015; 39(2):110-21.
    View PubMed
86. Tobin WO, Strand EA, Clark HM, Lowe VJ, Robertson CE, Pittock SJ. NMDA receptor encephalitis causing reversible caudate changes on MRI and PET imaging. Neurol Clin Pract. 2014 Dec; 4 (6):470-473
    View PubMed
87. Tobin WO, Lennon VA, Komorowski L, Probst C, Clardy SL, Aksamit AJ, Appendino JP, Lucchinetti CF, Matsumoto JY, Pittock SJ, Sandroni P, Tippmann-Peikert M, Wirrell EC, McKeon A. DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology. 2014 Nov 11; 83 (20):1797-803 Epub 2014 Oct 15
    View PubMed
88. Tobin WO, Kinsella JA, Kavanagh GF, O'Donnell JS, McGrath RT, Coughlan T, Collins DR, O'Neill D, Egan B, Tierney S, Feeley TM, Murphy RP, McCabe DJ. Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. J Neurol. 2014 Jul; 261(7):1405-12.
    
89. Kinsella JA, Tobin WO, Kavanagh GF, O'Donnell JS, McGrath RT, Tierney S, Feeley TM, Egan B, O'Neill D, Collins RD, Coughlan T, Harbison JA, Doherty CP, Madhavan P, Moore DJ, O'Neill SM, Colgan MP, Saqqur M, Murphy RP, Moran N, Hamilton G, McCabe DJ. Increased endothelial activation in recently symptomatic versus asymptomatic carotid artery stenosis and in cerebral microembolic-signal-negative patient subgroups. Eur J Neurol Jul. 2014 Jul; 21(7):969-e55.
    
90. Tobin WO, Weinshenker BG, Lucchinetti CF. Longitudinally extensive transverse myelitis. Curr Opin Neurol. 2014 Jun; 27 (3):279-89
    View PubMed
91. Power SP, Costello DJ, Tobin WO. Sexual dimorphism in clinical neurology - Predictors of successful lumbar puncture in an "expanding" population. Obesity (Silver Spring). 2014; 22(7):1747-9.
    View PubMed
92. Fazekas F Enzinger C Schmidt R Dichgans M Gaertner B Jungehulsing GJ Hennerici MG Heuschmann P Holzhausen M Kaps M Kessler C Martus P Putaala J Ropele S Tanislav C Tatlisumak T Norrving B Rolfs A, sifap1 Investigators. MRI in acute cerebral ischemia of the young: the Stroke in Young Fabry Patients (sifap1) Study. Neurology. 2013 Nov 26; 81(22):1914-21.
    
93. Kinsella JA, Tobin WO, Cox D, Coughlan T, Collins R, O'Neill D, Murphy RP, McCabe DJ. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®). J Stroke Cerebrovasc Dis. 2013 Oct; 22(7):e84-92.
    
94. Bradley D, Cronin S, Kinsella JA, Tobin WO, Mahon C, O'Brien M, Lonergan R, Cooney MT, Kennelly S, Collins DR, O'Neill D, Coughlan T, Smyth S, McCabe DJ. Frequent inaccuracies in ABCD2 scoring in non-stroke specialists' referrals to a daily Rapid Access Stroke Prevention service. J Neurol Sci. 2013 Sep 15; 332(1-2):30-4.
    
95. Kinsella JA, Tobin WO, Hamilton G, McCabe DJ. Platelet activation, function, and reactivity in atherosclerotic carotid artery stenosis: a systematic review of the literature. Int J Stroke. 2013 Aug.
    
96. Kinsella JA, Tobin WO, Tierney S, Feeley TM, Egan B, Collins DR, Coughlan T, O'Neill D, Harbison J, Madhavan P, Moore DJ, O'Neill SM, Colgan MP, Doherty CP, Murphy RP, Saqqur M, Moran N, Hamilton G, McCabe DJ. Increased platelet activation in early symptomatic vs. asymptomatic carotid stenosis and relationship with microembolic status: results from the Platelets and Carotid Stenosis Study. J Thromb Haemost. 2013 Jul.
    
97. von Sarnowski B Schminke U Tatlisumak T Putaala J Grittner U Kaps M Tobin WO Kinsella JA McCabe DJ Hennerici MG Fazekas F Norrving B Kessler C Rolfs A, sifap1 investigators. Prevalence of stenoses and occlusions of brain-supplying arteries in young stroke patients. Neurology. 2013 Apr 2; 80(14):1287-94.
    
98. Tobin WO, Kinsella JA, Coughlan T, Collins DR, O'Neill D, Murphy RP, Egan B, Tierney S, Feeley TM, McCabe DJ. High on-treatment platelet reactivity on commonly prescribed antiplatelet agents following transient ischaemic attack or ischaemic stroke: results from the Trinity Antiplatelet Responsiveness (TRAP) study. Eur J Neurol. 2013 Feb; 20(2):344-52.
    
99. Bartley M, Bokde AL, Ewers M, Faluyi YO, Tobin WO, Snow A, Connolly J, Delaney C, Coughlan T, Collins DR, Hampel H, O'Neill D. Subjective memory complaints in community dwelling healthy older people: the influence of brain and psychopathology. Int J Geriatr Psychiatry. 2012 Aug; 27(8):836-43.
    
100. Bartley M, Bokde AL, Ewers M, Faluyi YO, Tobin WO, Snow A, Connolly J, Delaney C, Coughlan T, Collins DR, Hampel H, O'Neill D. Subjective memory complaints in community dwelling healthy older people: the influence of brain and psychopathology. Int J Geriatr Psychiatry. 2012 Aug; 27 (8):836-43 Epub 2011 Sept 27
     View PubMed
101. Mullane D, Williams L, Merwick A, Tobin WO, McGuigan C. Drug induced aseptic meningitis caused by intravenous immunoglobulin therapy. Ir Med J Jun. 2012 Jun; 105(6):182-3.
     
102. Kinsella JA, Tobin WO, Cogan N, McCabe DJ. Interobserver agreement in ABCD scoring between non-stroke specialists and vascular neurologists following suspected TIA is only fair. J Neurol. 2011 Jun; 258(6):1001-7.
     
103. Tobin WO, Kinsella JA, Collins DR, Coughlan T, O'Neill D, Egan B, Tierney S, Feeley TM, Murphy RP, McCabe DJ. Enhanced ex vivo inhibition of platelet function following addition of dipyridamole to aspirin after transient ischaemic attack or ischaemic stroke: first results from the TRinity AntiPlatelet responsiveness (TrAP) study. Br J Haematol. 2011 Mar; 152(5):640-7.
     
104. Tobin WO, Killeen R, Kinsella JA, McCabe DJ. Dual origin of the left vertebral artery: extracranial MRA and CTA findings. J Neurol Sci 15. 2010 Nov 15; 298(1-2):150-2.
     
105. Regan J, Walshe M, Tobin WO. Immediate effects of thermal-tactile stimulation on timing of swallow in idiopathic Parkinson's disease. Dysphagia. 2010 Sep; 25(3):207-15.
     
106. McCabe DJ, Kinsella JA, Tobin WO. Left atrial appendage occlusion in non-valvular atrial fibrillation. Lancet. 2009 Aug 15; 374(9689):504-6.
     
107. Bartley M, Tobin WO, Collins R, O'Neill D. Stroke and newspapers: inattention or neglect? J Stroke Cerebrovasc Dis. 2009 Jul-Aug; 18(4):259-61.
     
108. Bartley M, Tobin WO, Collins R, O'Neill D. Stroke and newspapers: inattention or neglect? J Stroke Cerebrovasc Dis. 2009 Jul-Aug; 18 (4):259-61
     View PubMed
109. Tobin WO, Hentz JG, Bobrow BJ, Demaerschalk BM. Identification of stroke mimics in the emergency department setting. J Brain Dis. 2009; 1:19-22 Epub 2009 Mar 31
     View PubMed
110. Tobin WO, Spencer BR, Demaerschalk BM. Herpes zoster in the T1 dermatome presenting with Horner's syndrome, radicular weakness, and postherpetic neuralgia. International Medical Case Reports Journal.. 2008; 1: 1-2.